Avantor Investor Day Presentation Deck

BIOSCIENCE PRODUCTION: Leading provider of mission-critical, high-purity technologies F REVENUE ~$2.3B 2023E ADJ. OPERATING MARGIN ~26% 2023E 2023E revenue based on midpoint of FY 2023 guidance, as of Q3 2023 earnings call. Segment financials based on management estimates for FY 2023. Effective date for the new segment structure is 1/1/24. NEW OPERATING MODEL High-purity, custom materials provide critical functionality to products in demanding environments Proprietary manufacturing and purification technology deliver impurity levels as low as parts per trillion Regulatory and quality expertise for tightly regulated markets, driving highly recurring, spec'd in revenue Navantor™ 20

View entire presentation